← Eichor
Condition: Nutrition Labeling Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nutrition Labeling

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Ad
Phase 2 · 2 location(s) · Golo · NCT05844644A Food-Effect Study of CX11 in Healthy Participants
Phase 1 · 1 location(s) · Vincentage Pharma Co., Ltd · NCT07349381Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Phase 2/Phase 3 · 1 location(s) · Xiaojun Chen · NCT05316493Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome
Phase N/A · 10 location(s) · Fresenius Kabi · NCT06274788Remission of Diabetes With Lifestyle Intervention for Malaysian Patients
NA · 2 location(s) · Winnie Chee Siew Swee · NCT07270068Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Ma
Phase 4 · 21 location(s) · Chengdu Qingshan Likang Pharmaceutical Co., Ltd · NCT06597201Nutritional Supplementation in Head and Neck Cancers
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05379712Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Phase 4 · 5 location(s) · Fresenius Kabi · NCT06049680Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Ca
Phase 3 · 44 location(s) · Amgen · NCT07575399The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
NA · 2 location(s) · Nuritas Ltd · NCT07322653The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients
NA · 1 location(s) · SHUANG ZHENG JIA, PhD · NCT06349148A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Phase 2/Phase 3 · 4 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT07284511Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
NA · 2 location(s) · Flevoziekenhuis · NCT04852198Monthly Boluses Versus Daily Doses for Correcting Blood Vitamin D Deficit in Obese Children and Adolescents
Phase 3 · 4 location(s) · Hospices Civils de Lyon · NCT03516968Vitamin D and Polycystic Ovarian Syndrome (PCOS)
Phase 2 · 2 location(s) · Aga Khan University · NCT03989778A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Phase 4 · 21 location(s) · Eli Lilly and Company · NCT07438444A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · 40 location(s) · Eli Lilly and Company · NCT06857942A Study of CSTI-500 in Patients With Prader-Willi Syndrome
Phase 2 · 1 location(s) · ConSynance Therapeutics · NCT07348601Supermarket Labelling and Taxation Study
NA · 1 location(s) · University of Liverpool · NCT07339982Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NA · 9 location(s) · Nantes University Hospital · NCT07378072Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas
NA · 1 location(s) · University of Paris 13 · NCT07531849A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of C
Phase 1 · 2 location(s) · AstraZeneca · NCT07013643A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psori
Phase 4 · 55 location(s) · Eli Lilly and Company · NCT06864026Time Restricted Eating in Childhood Obesity (TRECO)
NA · 2 location(s) · Xiaoyan Shi · NCT06583447Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese o
Phase 3 · 1 location(s) · Gan & Lee Pharmaceuticals. · NCT07150975Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
NA · 17 location(s) · University of Leipzig · NCT03469609A Study of Pitolisant in Patients With Prader-Willi Syndrome
Phase 3 · 54 location(s) · Harmony Biosciences Management, Inc. · NCT06366464Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
Phase 2 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07521631Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study
NA · 1 location(s) · Nottingham University Hospitals NHS Trust · NCT06572345
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.